Design and baseline characteristics of STEP-HFpEF program evaluating semaglutide in patients with obesity HFpEF phenotype
"The good news is that the newer GLP-1 and GIP and GRA combinations appear to preserve more lean muscle mass compared to older formulations, especially when paired with sufficient protein, creatine, exercise and hydration, so we can achieve safer weight loss without sacrificing how we look." Dr
Liraglutide vs insulin glargine and placebo in combination with metformin and sulphonylurea therapy in type 2 diabetes mellitus: a randomized controlled trial (LEAD-5 met + SU)
As a result, you feel weaker, your metabolism slows, and plateaus hit sooner
This coverage gap makes affordable alternatives particularly important for people on government insurance programs
Whether they persist or resolve with continued use is not yet fully characterised from long-term data